Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, June 17, 2016
Evolocumab could be more effective than ezetimibe in lowering cholesterol in statin-intolerant patients
›
Ezetimibe atorvasta...
Thursday, June 16, 2016
Inhalable form of Ambrisentan drug could offer faster-acting treatment option for pulmonary edema
›
In a new study, researchers show an aerosolized, inhalable form of the drug Ambrisentan could offer a faster-acting treatment option for p...
Tuesday, June 14, 2016
Adding liraglutide to diet and exercise plan may help people lose weight, reduce diabetes risk
›
In continuation of my update on liraglutide For people with prediabetes who are overweight or obese, adding 3.0 mg of liraglutide for...
Monday, June 13, 2016
Researchers design more effective version of FDA-approved epilepsy drug with fewer side effects
›
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-...
Friday, June 10, 2016
NTU researchers make breakthrough to tackle growing concern of antibiotic resistance
›
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have discovered that antibiotics can continue to be effective if...
Thursday, June 9, 2016
U of S-led researchers develop novel class of compounds for effective cancer treatment
›
A novel class of compounds developed by a University of Saskatchewan (U of S)-led research team could yield more effective and less toxic ...
Wednesday, June 8, 2016
Plitidepsin in combination with dexamethasone shows top-line results in Phase III multiple myeloma trial
›
In continuation of my updates on dexamethasone and Aplidin (plitidepsin) PharmaMar (MSE:PHM) announced positive top-line...
Tuesday, June 7, 2016
Gleevec could be novel therapeutic agent for type 2 diabetes
›
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloi...
Monday, June 6, 2016
New drug regimens could significantly improve treatment for tuberculosis
›
Researchers from UCLA and Shanghai Jiao Tong University have made an important step toward a substantially faster and more effective treat...
Melatonin appears to suppress growth of breast cancer stem cells
›
In continuation of my update on Melatonin M elatonin, a hormone produced in the human brain, appears to suppress the growth of breast...
Friday, June 3, 2016
Mycophenolate mofetil drug seems safe, effective in treating autoimmune hepatitis
›
New research indicates that mycophenolate mofetil, a drug that is usually used to prevent rejection after kidney, heart or liver tra...
Experimental drug may become key tool to target triple-negative breast cancer with immunotherapy
›
Previous studies at the University of Colorado Cancer Center show that the experimental drug AMPI-109 potently kills triple-negative b...
Thursday, June 2, 2016
Xalkori Approved For Rare Genetic Form of Lung Cancer
›
In continuation of my update on Xalkori (crizotinib) Xalkori (crizotinib) has been approved by the U.S. Food and Drug Administr...
Teva Receives Complete Response Letter for NDA for SD-809 for the Treatment of Chorea Associated with Huntington Disease
›
Teva Pharmaceutical Industries Ltd. announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administr...
Wednesday, June 1, 2016
FDA Grants Spectrum Pharmaceuticals Approval of Evomela (melphalan) for Injection
›
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus i...
‹
›
Home
View web version